Gary V. Cantrell
Corporate Officer/Principal bei North Carolina State University
Vermögen: 23 299 $ am 30.04.2024
Profil
Gary V.
Cantrell currently works at North Carolina State University, as Principal and Averaden LLC, as Principal from 2015.
Mr. Cantrell also formerly worked at Yasoo Health, Inc., as Chief Executive Officer from 2007 to 2015, Vyrix Pharmaceuticals, Inc., as Independent Director from 2014 to 2015, GlaxoSmithKline, Inc., as Group Director-Non Promoted Brands, Flexible Stenting Solutions, Inc., as Director from 2008 to 2013, Yasoo Health Ltd., as Director, Aytu Biopharma, Inc., as Independent Director from 2016 to 2022, Accentia Biopharmaceuticals, Inc., as Executive Vice President-Sales & Marketing, TEAMM Pharmaceuticals, Inc., as Executive Vice President-Sales & Marketing from 2001 to 2006, and The Catevo Group, Inc., as President from 2006 to 2007.
Mr. Cantrell received his undergraduate degree from Wichita State University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
AYTU BIOPHARMA, INC.
0,15% | 21.12.2022 | 8 204 ( 0,15% ) | 23 299 $ | 30.04.2024 |
Aktive Positionen von Gary V. Cantrell
| Unternehmen | Position | Beginn |
|---|---|---|
| North Carolina State University | Corporate Officer/Principal | - |
| Averaden LLC | Corporate Officer/Principal | 01.06.2015 |
Ehemalige bekannte Positionen von Gary V. Cantrell
| Unternehmen | Position | Ende |
|---|---|---|
| AYTU BIOPHARMA, INC. | Direktor/Vorstandsmitglied | 31.12.2022 |
Vyrix Pharmaceuticals, Inc.
 Vyrix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vyrix Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It maximizes the clinical and commercial potential of its late-stage sexual dysfunction products. The company is currently focused on advancing the development of Zertane™ for Premature Ejaculation (PE) in the US and around the world. Vyrix Pharmaceuticals was founded on November 18, 2013 and is headquartered in Greenwood Village, CO. | Direktor/Vorstandsmitglied | 01.04.2015 |
| Yasoo Health, Inc. | Vorstandsvorsitzender | 01.01.2015 |
Flexible Stenting Solutions, Inc.
 Flexible Stenting Solutions, Inc. Medical/Nursing ServicesHealth Services Flexible Stenting Solutions, Inc. manufactures and distributes medical devices. It develops third-generation flexible peripheral arterial, venous, neurovascular and biliary stents. The company was founded by Janet W. Burpee in 2006 and is headquartered in Eatontown, NJ. | Direktor/Vorstandsmitglied | 01.03.2013 |
The Catevo Group, Inc.
 The Catevo Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Catevo Group, Inc. provided business consulting services. It offered strategic marketing, integrated communications, consulting and technology solutions. The company was founded in 2006 and was headquartered in Raleigh, NC. | Präsident | 01.06.2007 |
Ausbildung von Gary V. Cantrell
| Wichita State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AYTU BIOPHARMA, INC. | Health Technology |
| Private Unternehmen | 9 |
|---|---|
Accentia Biopharmaceuticals, Inc.
 Accentia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Accentia Biopharmaceuticals, Inc. engages in the commercialization of patent-protected disruptive healthcare technologies. It offers products under the BiovaxID., Revimmune, and SinuNase brands. The company was founded in 2002 and is headquartered in Tampa, FL. | Health Technology |
The Catevo Group, Inc.
The Catevo Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Catevo Group, Inc. provided business consulting services. It offered strategic marketing, integrated communications, consulting and technology solutions. The company was founded in 2006 and was headquartered in Raleigh, NC. | Commercial Services |
TEAMM Pharmaceuticals, Inc.
 TEAMM Pharmaceuticals, Inc. Medical DistributorsDistribution Services TEAMM Pharmaceuticals, Inc. engaged in the business of selling prescription based pharmaceutical products. The company was headquartered in Morrisville, NC. | Distribution Services |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
Vyrix Pharmaceuticals, Inc.
Vyrix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vyrix Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It maximizes the clinical and commercial potential of its late-stage sexual dysfunction products. The company is currently focused on advancing the development of Zertane™ for Premature Ejaculation (PE) in the US and around the world. Vyrix Pharmaceuticals was founded on November 18, 2013 and is headquartered in Greenwood Village, CO. | Health Technology |
| Yasoo Health, Inc. | |
| Yasoo Health Ltd. | |
Flexible Stenting Solutions, Inc.
Flexible Stenting Solutions, Inc. Medical/Nursing ServicesHealth Services Flexible Stenting Solutions, Inc. manufactures and distributes medical devices. It develops third-generation flexible peripheral arterial, venous, neurovascular and biliary stents. The company was founded by Janet W. Burpee in 2006 and is headquartered in Eatontown, NJ. | Health Services |
| Averaden LLC |
